PRMT5 and WDR77 are upregulated in a number of human cancers, including breast cancer [38], pancreatic cancer [39], glioblastoma [40], and lung cancer [41], and associated with poor survival, underscoring their essential role in oncogenesis [42]. This evidence concerns the gene PRMT5 and glioblastoma.